Forest Lexapro “Not Approvable” For Social Anxiety Disorder
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s concerns regarded reliability of data from one of the pivotal studies, Forest says – an additional study may be necessary. Forest announced Lexapro was deemed “not approvable” for panic disorder March 1.